ArticleBone & joint open2025
Long-term results of CT-guided radiofrequency ablation therapy in patients with osteoid osteoma : retrospective outcome analysis.
Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What to do to beat Langerhans cell histiocytosis of bone? A narrative review and case series of radiofrequency ablation.EFORT open reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This research aims to review the long-term outcomes of CT-guided radiofrequency thermal ablation (RFA) in managing patients with osteoid osteoma (OO). Methods: A total of 210 patients, with a mean age of 16.6 years, treated with CT-guided RFA between January 2005 and December 2022, were retrospectively studied. The research assessed patients' post-procedure clinical follow-up, recording treatment success and complications. Cox regression analysis, conducted in both univariate and multiple models, examined the impact of independent variables on recurrence time. Results: The average follow-up was 103.7 months. In the first 24 hours after the treatment, all patients had less OO pain. Successful outcomes without recurrence were achieved in 200 out of 210 patients (95.2%). Univariate analysis indicated that sex did not have a significant impact on recurrence (p = 0.657); however, recurrence was significantly associated with younger age (p = 0.004). Conclusion: This research shows that CT-guided RFA for OO patients relieves pain quickly, has low recurrence rates, and minimal complications. Younger patients should be monitored for an extended duration due to the influence of age on recurrence rates.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.